Free Trial
→ URGENT: This Altcoin Opportunity Won’t Wait – Act Now (From Crypto Swap Profits) (Ad) Free SPRY Stock Alerts

ARS Pharmaceuticals (SPRY) SEC Filings & 10K Form

ARS Pharmaceuticals logo
$11.48 -0.28 (-2.38%)
(As of 12:43 PM ET)
Compare

Recent ARS Pharmaceuticals SEC Filings

Export to Excel
DateFilerForm TypeView
12/13/2024
6:52 PM		ARS Pharmaceuticals, Inc. (Issuer)
ARS Pharmaceuticals (Issuer)
Dorsey Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2024
6:53 PM		ARS Pharmaceuticals, Inc. (Issuer)
ARS Pharmaceuticals (Issuer)
Chakma Justin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2024
4:24 PM		ARS Pharmaceuticals, Inc. (Subject)
ARS Pharmaceuticals (Subject)
Chakma Justin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/12/2024
4:41 PM		ARS Pharmaceuticals, Inc. (Issuer)
ARS Pharmaceuticals (Issuer)
Chakma Justin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2024
4:02 PM		ARS Pharmaceuticals, Inc. (Subject)
ARS Pharmaceuticals (Subject)
Chakma Justin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/11/2024
5:30 PM		ARS Pharmaceuticals, Inc. (Issuer)
ARS Pharmaceuticals (Issuer)
Lowenthal Richard E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
5:30 PM		ARS Pharmaceuticals, Inc. (Issuer)
ARS Pharmaceuticals (Issuer)
Tanimoto Sarina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
4:31 PM		ARS Pharmaceuticals, Inc. (Subject)
ARS Pharmaceuticals (Subject)
Dorsey Brian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/10/2024
3:48 PM		ARS Pharmaceuticals, Inc. (Subject)
ARS Pharmaceuticals (Subject)
Chakma Justin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/10/2024
10:15 AM		ARS Pharmaceuticals, Inc. (Subject)
ARS Pharmaceuticals (Subject)
Lowenthal Richard E (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/09/2024
4:43 PM		ARS Pharmaceuticals, Inc. (Issuer)
ARS Pharmaceuticals (Issuer)
Tanimoto Sarina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
4:25 PM		ARS Pharmaceuticals, Inc. (Issuer)
ARS Pharmaceuticals (Issuer)
Lowenthal Richard E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
11:38 AM		ARS Pharmaceuticals, Inc. (Subject)
ARS Pharmaceuticals (Subject)
Shawver Laura (Reporting)
Form 144/A
12/06/2024
6:15 PM		ARS Pharmaceuticals, Inc. (Issuer)
ARS Pharmaceuticals (Issuer)
Chakma Justin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2024
4:30 PM		ARS Pharmaceuticals, Inc. (Subject)
ARS Pharmaceuticals (Subject)
Chakma Justin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/05/2024
4:06 PM		ARS Pharmaceuticals, Inc. (Subject)
ARS Pharmaceuticals (Subject)
Chakma Justin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/03/2024
4:25 PM		ARS Pharmaceuticals, Inc. (Subject)
ARS Pharmaceuticals (Subject)
Chakma Justin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/02/2024
6:01 PM		ARS Pharmaceuticals, Inc. (Subject)
ARS Pharmaceuticals (Subject)
Chakma Justin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/02/2024
5:22 PM		ARS Pharmaceuticals, Inc. (Subject)
ARS Pharmaceuticals (Subject)
Shawver Laura (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/02/2024
3:42 PM		ARS Pharmaceuticals, Inc. (Subject)
ARS Pharmaceuticals (Subject)
Karas Eric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/27/2024
3:11 PM		ARS Pharmaceuticals, Inc. (Issuer)
ARS Pharmaceuticals (Issuer)
Chakma Justin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2024
3:30 PM		ARS Pharmaceuticals, Inc. (Issuer)
ARS Pharmaceuticals (Issuer)
Tanimoto Sarina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2024
3:30 PM		ARS Pharmaceuticals, Inc. (Issuer)
ARS Pharmaceuticals (Issuer)
Lowenthal Richard E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2024
2:21 PM		ARS Pharmaceuticals, Inc. (Subject)
ARS Pharmaceuticals (Subject)
Chakma Justin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/13/2024
7:16 PM		ARS Pharmaceuticals, Inc. (Issuer)
ARS Pharmaceuticals (Issuer)
DEERFIELD MANAGEMENT COMPANY, L.P. (0001009258) (Reporting)
Deerfield Mgmt III, L.P. (Reporting)
Deerfield Mgmt IV, L.P. (Reporting)
Deerfield Private Design Fund III, L.P. (Reporting)
Deerfield Private Design Fund IV, L.P. (Reporting)
Flynn James E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
6:02 AM		ARS Pharmaceuticals, Inc. (Filer)
ARS Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/13/2024
6:00 AM		ARS Pharmaceuticals, Inc. (Filer)
ARS Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
3:30 PM		ARS Pharmaceuticals, Inc. (Issuer)
ARS Pharmaceuticals (Issuer)
Lowenthal Richard E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/17/2024
3:30 PM		ARS Pharmaceuticals, Inc. (Issuer)
ARS Pharmaceuticals (Issuer)
Tanimoto Sarina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/17/2024
3:30 PM		ARS Pharmaceuticals, Inc. (Issuer)
ARS Pharmaceuticals (Issuer)
Scott Kathleen D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2024
3:01 PM		ARS Pharmaceuticals, Inc. (Subject)
ARS Pharmaceuticals (Subject)
Scott Kathleen D. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/15/2024
10:28 AM		ARS Pharmaceuticals, Inc. (Subject)
ARS Pharmaceuticals (Subject)
Tanimoto Sarina (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/15/2024
6:02 AM		ARS Pharmaceuticals, Inc. (Filer)
ARS Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/10/2024
3:27 PM		ARS Pharmaceuticals, Inc. (Issuer)
ARS Pharmaceuticals (Issuer)
Lowenthal Richard E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2024
3:28 PM		ARS Pharmaceuticals, Inc. (Issuer)
ARS Pharmaceuticals (Issuer)
Tanimoto Sarina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/23/2024
3:15 PM		ARS Pharmaceuticals, Inc. (Filer)
ARS Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2024
3:26 PM		ARS Pharmaceuticals, Inc. (Issuer)
ARS Pharmaceuticals (Issuer)
Lowenthal Richard E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2024
3:29 PM		ARS Pharmaceuticals, Inc. (Issuer)
ARS Pharmaceuticals (Issuer)
Tanimoto Sarina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2024
3:30 PM		ARS Pharmaceuticals, Inc. (Issuer)
ARS Pharmaceuticals (Issuer)
Karas Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2024
3:06 PM		ARS Pharmaceuticals, Inc. (Subject)
ARS Pharmaceuticals (Subject)
Karas Eric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/12/2024
3:24 PM		ARS Pharmaceuticals, Inc. (Issuer)
ARS Pharmaceuticals (Issuer)
Lowenthal Richard E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)

It’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life-changing for those who are prepared. Why? Because altcoin prices are about to explode.

>> Register for the Workshop Now
09/12/2024
3:25 PM		ARS Pharmaceuticals, Inc. (Issuer)
ARS Pharmaceuticals (Issuer)
Tanimoto Sarina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2024
9:31 AM		ARS Pharmaceuticals, Inc. (Subject)
ARS Pharmaceuticals (Subject)
Lowenthal Richard E (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/28/2024
3:30 PM		ARS Pharmaceuticals, Inc. (Issuer)
ARS Pharmaceuticals (Issuer)
Thompson Peter A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2024
5:41 PM		ARS Pharmaceuticals, Inc. (Issuer)
ARS Pharmaceuticals (Issuer)
Thompson Peter A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2024
5:38 PM		ARS Pharmaceuticals, Inc. (Issuer)
ARS Pharmaceuticals (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VI LLC (Reporting)
ORBIMED CAPITAL LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2024
5:43 PM		ARS Pharmaceuticals, Inc. (Subject)
ARS Pharmaceuticals (Subject)
ORBIMED CAPITAL LLC (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/21/2024
5:47 PM		ARS Pharmaceuticals, Inc. (Issuer)
ARS Pharmaceuticals (Issuer)
Lowenthal Richard E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2024
5:48 PM		ARS Pharmaceuticals, Inc. (Issuer)
ARS Pharmaceuticals (Issuer)
Tanimoto Sarina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2024
5:49 PM		ARS Pharmaceuticals, Inc. (Issuer)
ARS Pharmaceuticals (Issuer)
Scott Kathleen D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2024
5:51 PM		ARS Pharmaceuticals, Inc. (Issuer)
ARS Pharmaceuticals (Issuer)
Karas Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2024
5:51 PM		ARS Pharmaceuticals, Inc. (Issuer)
ARS Pharmaceuticals (Issuer)
Dorsey Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
3:18 PM		ARS Pharmaceuticals, Inc. (Subject)
ARS Pharmaceuticals (Subject)
Scott Kathleen D. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/15/2024
3:30 PM		ARS Pharmaceuticals, Inc. (Issuer)
ARS Pharmaceuticals (Issuer)
Lowenthal Richard E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2024
3:30 PM		ARS Pharmaceuticals, Inc. (Issuer)
ARS Pharmaceuticals (Issuer)
Tanimoto Sarina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2024
3:30 PM		ARS Pharmaceuticals, Inc. (Issuer)
ARS Pharmaceuticals (Issuer)
Dorsey Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
6:59 AM		ARS Pharmaceuticals, Inc. (Filer)
ARS Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/18/2024
3:30 PM		ARS Pharmaceuticals, Inc. (Issuer)
ARS Pharmaceuticals (Issuer)
Tanimoto Sarina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2024
3:30 PM		ARS Pharmaceuticals, Inc. (Issuer)
ARS Pharmaceuticals (Issuer)
Lowenthal Richard E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2024
11:07 AM		ARS Pharmaceuticals, Inc. (Subject)
ARS Pharmaceuticals (Subject)
Tanimoto Sarina (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/11/2024
4:03 PM		ARS Pharmaceuticals, Inc. (Issuer)
ARS Pharmaceuticals (Issuer)
Lowenthal Richard E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2024
4:04 PM		ARS Pharmaceuticals, Inc. (Issuer)
ARS Pharmaceuticals (Issuer)
Tanimoto Sarina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2024
2:15 PM		ARS Pharmaceuticals, Inc. (Filer)
ARS Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/28/2024
5:46 AM		ARS Pharmaceuticals, Inc. (Filer)
ARS Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/24/2024
4:06 PM		ARS Pharmaceuticals, Inc. (Issuer)
ARS Pharmaceuticals (Issuer)
Dadoo Rajeev (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
4:13 PM		ARS Pharmaceuticals, Inc. (Issuer)
ARS Pharmaceuticals (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund II, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
4:00 PM		ARS Pharmaceuticals, Inc. (Filer)
ARS Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2024
7:47 PM		ARS Pharmaceuticals, Inc. (Subject)
ARS Pharmaceuticals (Subject)
Pratik Shah Living Trust dated June 15, 2011 (Filed by)
Form SC 13D/A
06/17/2024
5:39 PM		ARS Pharmaceuticals, Inc. (Issuer)
ARS Pharmaceuticals (Issuer)
Shah Pratik (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
3:30 PM		ARS Pharmaceuticals, Inc. (Issuer)
ARS Pharmaceuticals (Issuer)
Lowenthal Richard E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
6:18 PM		ARS Pharmaceuticals, Inc. (Subject)
ARS Pharmaceuticals (Subject)
Pratik Shah Living Trust dated June 15, 2011 (Filed by)
Form SC 13D/A
06/11/2024
10:36 AM		ARS Pharmaceuticals, Inc. (Subject)
ARS Pharmaceuticals (Subject)
Lowenthal Richard E (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/07/2024
8:09 PM		ARS Pharmaceuticals, Inc. (Issuer)
ARS Pharmaceuticals (Issuer)
Pratik Shah Living Trust dated June 15, 2011 (Reporting)
Shah Pratik (Reporting)
Form 4/A
06/07/2024
8:11 PM		ARS Pharmaceuticals, Inc. (Issuer)
ARS Pharmaceuticals (Issuer)
Shah Pratik (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
3:32 PM		ARS Pharmaceuticals, Inc. (Issuer)
ARS Pharmaceuticals (Issuer)
Pratik Shah Living Trust dated June 15, 2011 (Reporting)
Shah Pratik (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
6:51 PM		ARS Pharmaceuticals, Inc. (Issuer)
ARS Pharmaceuticals (Issuer)
Lowenthal Richard E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
6:52 PM		ARS Pharmaceuticals, Inc. (Issuer)
ARS Pharmaceuticals (Issuer)
Tanimoto Sarina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2024
6:01 AM		ARS Pharmaceuticals, Inc. (Filer)
ARS Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
5:57 PM		ARS Pharmaceuticals, Inc. (Issuer)
ARS Pharmaceuticals (Issuer)
Lowenthal Richard E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
5:59 PM		ARS Pharmaceuticals, Inc. (Issuer)
ARS Pharmaceuticals (Issuer)
Tanimoto Sarina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
3:08 PM		ARS Pharmaceuticals, Inc. (Filer)
ARS Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2024
5:17 PM		ARS Pharmaceuticals, Inc. (Issuer)
ARS Pharmaceuticals (Issuer)
Lowenthal Richard E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/24/2024
5:18 PM		ARS Pharmaceuticals, Inc. (Issuer)
ARS Pharmaceuticals (Issuer)
Tanimoto Sarina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2024
6:22 PM		ARS Pharmaceuticals, Inc. (Issuer)
ARS Pharmaceuticals (Issuer)
Lowenthal Richard E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2024
6:23 PM		ARS Pharmaceuticals, Inc. (Issuer)
ARS Pharmaceuticals (Issuer)
Tanimoto Sarina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2024
5:40 PM		ARS Pharmaceuticals, Inc. (Issuer)
ARS Pharmaceuticals (Issuer)
Lowenthal Richard E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2024
5:42 PM		ARS Pharmaceuticals, Inc. (Issuer)
ARS Pharmaceuticals (Issuer)
Tanimoto Sarina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2024
4:36 PM		ARS Pharmaceuticals, Inc. (Issuer)
ARS Pharmaceuticals (Issuer)
Lowenthal Richard E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2024
4:39 PM		ARS Pharmaceuticals, Inc. (Issuer)
ARS Pharmaceuticals (Issuer)
Tanimoto Sarina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2024
3:14 PM		ARS Pharmaceuticals, Inc. (Subject)
ARS Pharmaceuticals (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13D/A
03/27/2024
6:37 PM		ARS Pharmaceuticals, Inc. (Issuer)
ARS Pharmaceuticals (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund II, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Do this Before Elon’s Reveal on January 22nd (Ad)

Elon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.

I urge you to watch this video now.
03/26/2024
5:47 PM		ARS Pharmaceuticals, Inc. (Issuer)
ARS Pharmaceuticals (Issuer)
Tanimoto Sarina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2024
5:48 PM		ARS Pharmaceuticals, Inc. (Issuer)
ARS Pharmaceuticals (Issuer)
Lowenthal Richard E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2024
8:50 PM		ARS Pharmaceuticals, Inc. (Issuer)
ARS Pharmaceuticals (Issuer)
Tanimoto Sarina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2024
8:51 PM		ARS Pharmaceuticals, Inc. (Issuer)
ARS Pharmaceuticals (Issuer)
Lowenthal Richard E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2024
4:08 PM		ARS Pharmaceuticals, Inc. (Filer)
ARS Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/15/2024
6:52 PM		ARS Pharmaceuticals, Inc. (Issuer)
ARS Pharmaceuticals (Issuer)
Tanimoto Sarina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2024
6:55 PM		ARS Pharmaceuticals, Inc. (Issuer)
ARS Pharmaceuticals (Issuer)
Lowenthal Richard E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
11:56 AM		ARS Pharmaceuticals, Inc. (Filer)
ARS Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/01/2024
7:21 PM		ARS Pharmaceuticals, Inc. (Issuer)
ARS Pharmaceuticals (Issuer)
Tanimoto Sarina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:SPRY) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners
This drone stock is setting up to transform medical supply delivery
Drone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks.
The Tomorrow Investor | Sponsored
Healthcare Takes A Big Step Forward With The Help of A.I.
To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...
Wall Street Star | Sponsored
Is Starlink Set For The Largest IPO In History?
He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...
Paradigm Press | Sponsored
Uncover the Top Gold Stock of the Bull Market
Gold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?
Huge Alerts | Sponsored
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
It’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...
Crypto Swap Profits | Sponsored
DeFi Coin on Verge of Breakout!
The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years.
Crypto 101 Media | Sponsored
Seeing is believing…
Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...
Porter & Company | Sponsored
Please don’t take this warning lightly…
Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...
InvestorPlace | Sponsored